Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06124521 · ClinicalTrials.gov registry record · NA

Community Based Treatment for (ComBaT) Glaucoma

A NA study of Glaucoma, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT06124521 is a NA study of Glaucoma that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 60 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06124521, a NA study of Glaucoma, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this research is to evaluate if intervention and education can change the behavior of someone's willingness to see an eye care provider to prevent blindness and glaucoma. The researchers are investigating if adding additional resources improves participant access to care.

Conditions Studied

Interventions

  • BEHAVIORAL ComBaT Glaucoma

Study Locations (2)

Michigan

  • University of Michigan - Ann Arbor
  • Historic King Solomon Baptist Church - Detroit

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-10-18
Est. Completion 2027-05
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT06124521

The ClinicalTrials.gov registry entry for NCT06124521 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (93% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which ComBaT Glaucoma is the first listed.

NCT06124521 reports 2 study locations spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06124521 about?

NCT06124521 is a clinical study titled "Community Based Treatment for (ComBaT) Glaucoma". The purpose of this research is to evaluate if intervention and education can change the behavior of someone's willingness to see an eye care provider to prevent blindness and glaucoma. The researchers are investigating if adding additional resources improves participant access to care.

What is the current status of trial NCT06124521?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-10-18. Estimated completion is 2027-05.

What conditions does trial NCT06124521 study?

This clinical trial studies the following conditions: Glaucoma.

What interventions are being tested in trial NCT06124521?

The interventions under investigation include: ComBaT Glaucoma (BEHAVIORAL).

Who is sponsoring clinical trial NCT06124521?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06124521 being conducted?

This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.